The US Food and Drug Administration’s recent decision to more closely regulate COVID-19 antibody tests has raised some concerns for industry, a recent virtual town hall hosted by the agency indicates.
The FDA updated its guidance on both diagnostic and antibody tests, also known as serological tests, on 4 May. Under the new guidance, antibody test manufacturers must submit validation data...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?